Kudo M - Search Results

1

Phase 2 study of lenvatinib in patients with advanced hepatocellular carcinoma.

Ikeda K, Kudo M, Kawazoe S, Osaki Y, Ikeda M, Okusaka T, Tamai T, Suzuki T, Hisai T, Hayato S, Okita K, Kumada H. Ikeda K, et al. Among authors: kudo m. J Gastroenterol. 2017 Apr;52(4):512-519. doi: 10.1007/s00535-016-1263-4. Epub 2016 Oct 4. J Gastroenterol. 2017. PMID: 27704266 Free PMC article. Clinical Trial.

2

Transcatheter arterial chemoembolization of hepatocellular carcinoma: usefulness of coded phase-inversion harmonic sonography.

Minami Y, Kudo M, Kawasaki T, Kitano M, Chung H, Maekawa K, Shiozaki H. Minami Y, et al. Among authors: kudo m. AJR Am J Roentgenol. 2003 Mar;180(3):703-8. doi: 10.2214/ajr.180.3.1800703. AJR Am J Roentgenol. 2003. PMID: 12591679

3

Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score).

Kudo M, Chung H, Osaki Y. Kudo M, et al. J Gastroenterol. 2003;38(3):207-15. doi: 10.1007/s005350300038. J Gastroenterol. 2003. PMID: 12673442 Review.

4

Hepatobiliary and pancreatic: inflammatory pseudotumor of the liver.

Zheng RQ, Kudo M. Zheng RQ, et al. Among authors: kudo m. J Gastroenterol Hepatol. 2003 Aug;18(8):994. doi: 10.1046/j.1440-1746.2003.03132.x. J Gastroenterol Hepatol. 2003. PMID: 12859732 No abstract available.

5

Risk of HCV transmission after needlestick injury, and the efficacy of short-duration interferon administration to prevent HCV transmission to medical personnel.

Chung H, Kudo M, Kumada T, Katsushima S, Okano A, Nakamura T, Osaki Y, Kohigashi K, Yamashita Y, Komori H, Nishiuma S. Chung H, et al. Among authors: kudo m. J Gastroenterol. 2003;38(9):877-9. doi: 10.1007/s00535-003-1156-1. J Gastroenterol. 2003. PMID: 14569445

6

Percutaneous ultrasound-guided radiofrequency ablation with artificial pleural effusion for hepatocellular carcinoma in the hepatic dome.

Minami Y, Kudo M, Kawasaki T, Chung H, Ogawa C, Inoue T, Sakaguchi Y, Sakamoto H, Shiozaki H. Minami Y, et al. Among authors: kudo m. J Gastroenterol. 2003;38(11):1066-70. doi: 10.1007/s00535-003-1197-5. J Gastroenterol. 2003. PMID: 14673724

7

Local ablation therapy for hepatocellular carcinoma: current status and future perspectives.

Kudo M. Kudo M. J Gastroenterol. 2004;39(3):205-14. doi: 10.1007/s00535-003-1280-y. J Gastroenterol. 2004. PMID: 15064996 Review. No abstract available.

8

Hepatocellular carcinoma and NASH.

Kudo M. Kudo M. J Gastroenterol. 2004;39(4):409-11. doi: 10.1007/s00535-004-1332-y. J Gastroenterol. 2004. PMID: 15168260 No abstract available.

9

Hepatocellular carcinoma that ruptured during radiofrequency ablation therapy.

Kawasaki T, Kudo M, Chung H, Minami Y. Kawasaki T, et al. Among authors: kudo m. J Gastroenterol. 2004 Oct;39(10):1015-6. doi: 10.1007/s00535-003-1437-8. J Gastroenterol. 2004. PMID: 15549459 No abstract available.

10

Validation of a new prognostic staging system for hepatocellular carcinoma: the JIS score compared with the CLIP score.

Kudo M, Chung H, Haji S, Osaki Y, Oka H, Seki T, Kasugai H, Sasaki Y, Matsunaga T. Kudo M, et al. Hepatology. 2004 Dec;40(6):1396-405. doi: 10.1002/hep.20486. Hepatology. 2004. PMID: 15565571

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,562 results

Search Page

Filters